We are live on ! Find out more
KTOVW

Kitov Pharma Ltd. Warrants
KTOVW

Delisted

KTOVW was delisted on the 23rd of November, 2020.

Back to rankings

4 hedge funds and large institutions have $36K invested in Kitov Pharma Ltd. Warrants in 2019 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 4 → 4 (0)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

5% less capital invested

Capital invested by funds: $38K → $36K (-$2K)

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$61

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$719
Name Holding Trade Value Shares
Change 		Change in
Stake
WPSG
1
Wealth & Pension Services Group
Georgia
$20K – – –
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$10K -$719 -5,910 -6%
CAI
3
Capital Advisors Inc
Oklahoma
$6K – – –
UBS Group
4
UBS Group
Switzerland
– +$61 +501 +15%

KTOVW Hedge Fund Activity: Q3 2019 in Review

4 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Kitov Pharma Ltd. Warrants (KTOVW) for Q3 2019, worth a combined $36K — down 5.3% from $38K a quarter earlier.

Fund positioning in KTOVW was balanced in Q3 2019: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was UBS Group, adding an estimated $61. The largest seller was Susquehanna International Group, cutting an estimated $719.

  • 4 institutional investors held Kitov Pharma Ltd. Warrants (KTOVW) as of Q3 2019, unchanged from Q2 2019.
  • Funds reported $36K of Kitov Pharma Ltd. Warrants stock for Q3 2019, down 5.3% quarter-over-quarter.
  • 0 funds opened new Kitov Pharma Ltd. Warrants positions in Q3 2019 and 0 closed out.
  • The largest Kitov Pharma Ltd. Warrants buyer in Q3 2019 was UBS Group, an estimated $61 added.
  • The largest Kitov Pharma Ltd. Warrants seller in Q3 2019 was Susquehanna International Group, an estimated $719 sold.

Based on aggregated 13F filings for Q3 2019.